Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV001839134 | SCV002099054 | uncertain significance | Complement component 5 deficiency | 2021-03-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002482384 | SCV002788530 | uncertain significance | Complement component 5 deficiency; Eculizumab, poor response to | 2021-12-29 | criteria provided, single submitter | clinical testing |